A new research paper titled "Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable ...
With the advancement of imaging technologies, the application of 18 F-FDG PET/CT in the diagnosis and management of cervical cancer has garnered increasing attention. This article aims to review the ...
Gastric cancers accounted for 11,180 deaths in the U.S. alone in 2021, and almost two-thirds are diagnosed at an advanced stage. A recent study evaluated the efficacy of 18F-FDG PET/CT to determine ...
Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC). This is an ASCO Meeting Abstract from the 2017 ...
For patients with head and neck squamous cell carcinoma, utilizing fluorodeoxyglucose-(FDG)-PET/CT imaging to assess their response to chemoradiation significantly increases the accuracy in ...
Multiple antigen stimulating cellular therapy (MASCT)-I for metastatic urothelial carcinoma (mUC): A multicenter, phase I study (MASCT-I-1001). This is an ASCO Meeting Abstract from the 2023 ASCO ...
image: 68Ga-ABY-025 PET/CT and 18F-FDG PET/CT images at baseline with 18F-FDG PET/CT follow-up after 2 cycles of treatment in biopsy-confirmed HER2-positive disease. (A) Patient with high 68Ga-ABY-025 ...
Ovarian Cancer (OC) is the leading cause of gynecologic cancer–related deaths and the fifth most frequent cause of cancer mortality in women (5%) following lungs (25%), colon-rectum (14%), breast (8%) ...
“FDG-PET is generally considered as a useful metabolic evaluation tool, while it is also thought to have an emerging role for assessment of systemic therapy response.” “Results for malignant pleural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results